SCHEMBL1013872

SCHEMBL1013872

Cc1ccc(Br)cc1NCC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MAPT P10636 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
IDO1 P14902 1/20 0.38
AR P10275 1/20 0.37
ESR1 P03372 2/20 0.35
SIGMAR1 Q99720 2/20 0.35
KDM6B O15054 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14515399 0.81 HTT (0.58) HTTMAPTALDH1A1MEN1KMT2A
SCHEMBL1528683 0.80 AAK1 (0.42) MAPTIDO1ESR1KDM6BKDM4C
SCHEMBL1015921 0.79 RECQL (0.60) HTTMAPTALDH1A1MEN1KMT2A
SCHEMBL21131436 0.78 RAPGEF4 (0.47) HTTMAPTALDH1A1MEN1KMT2A
SCHEMBL17845271 0.78 MAPT (0.44) HTTMAPTALDH1A1MEN1KMT2A
SCHEMBL18477378 0.76 AAK1 (0.44) HTTMAPTALDH1A1IDO1ESR1
SCHEMBL12838884 0.76 HTT (0.36) HTTCA1CA2MAPTALDH1A1
SCHEMBL25235960 0.75 KDM6B (0.56) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL15854539 0.75 LMNA (0.42) HTTCA1CA2MAPTALDH1A1
SCHEMBL14831803 0.74 AR (0.46) HTTALDH1A1MEN1KMT2AAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 HTT 1349/4885CA1 3623/4885CA2 4350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.